online course, starting September 2015

Objectives
– to understand how to evaluate the effects of medicines and therapeutic interventions both during drug development and clinical use.
– to know the main methodological and ethical characteristics and limitations of randomized clinical trials.
– to understand the differences between efficacy and effectiveness.
– to know the basic concepts and classification of the pharmacoepidemiological studies designed to evaluate therapeutic interventions.
– to identify information gaps in selected therapeutic areas (e.g. cardiovascular, psychiatry, diabetes care).

Topics
– Patients, medicines and prescribing in society. Life cycle of medicines.
– The knowledge-building process of the effects and adverse effects of medicines during their development and clinical use.
– Overview of studies to detect and to evaluate the risk associated with therapeutic interventions. Scope, uses and limitations.
– The need to monitor the medicines prescribing process.
– Introduction to the study of the use of medicines in clinical practice.

Trainers’ team
Janice Fuller (from Amgen NV), Albert Figueras [module coordinator], Prof. Joan-Ramon Laporte, Joseph-Maria Castel, Eduard Diogène, Roser Llop, Dr Dolores Rodriguez (from Fundació Institut Catalá de Farmacologia – Universitat Autonoma de Barcelona), Jamie Robinson (from F. Hoffmann-La Roche Ltd) and Ulf Bergman (from Karolinska Institutet)

Dates

For more Information and application click here.

Tip: More up to date educational events dealing with healthcare can be found online on the Education Database »medicine & health«.